IL6 and COVID-19: Compared to patients with COVID-19 who do not have diabetes, those with diabetes had heightened inflammatory responses (characterized by elevated neutrophils, serum ferritin, IL-6, CRP, and erythrocyte sedimentation rate) and suppressed immunity (marked by significantly reduced lymphocyte levels) (41).